Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2020   53,045,510      
Beginning balance at Dec. 31, 2020 $ 291,422 $ 53,046 $ 289,344 $ (3,174) $ (47,794)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) (18,529)       (18,529)
Other comprehensive income (loss) (966)     (966)  
Ending balance (in shares) at Mar. 31, 2021   53,045,510      
Ending balance at Mar. 31, 2021 $ 271,927 $ 53,046 289,344 (4,140) (66,323)
Beginning balance (in shares) at Dec. 31, 2021 157,237,435 157,237,435      
Beginning balance at Dec. 31, 2021 $ 1,083,310 $ 157,237 1,670,033 (7,135) (736,825)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation 5,724   5,724    
Ordinary shares issued related to share-based compensation (in shares)   5,952,992      
Ordinary shares issued related to founders advisory fees - related party 13,783 $ 5,954 7,829    
Ordinary shares issued related to warrants exercised (in shares)   44,115      
Ordinary shares issued related to warrants exercised 529 $ 44 485    
Net income (loss) 37,811       37,811
Other comprehensive income (loss) $ 126     126  
Ending balance (in shares) at Mar. 31, 2022 163,234,542 163,234,542      
Ending balance at Mar. 31, 2022 $ 1,141,283 $ 163,235 $ 1,684,071 $ (7,009) $ (699,014)